Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Bruceantin, a novel inhibitor of peptide bond formation.

Literature DB >> 343816

Bruceantin, a novel inhibitor of peptide bond formation.

M Fresno, A Gonzales, D Vazquez, A Jiménez.

Abstract

Entities: Chemical

Mesh：

Substances：

Year: 1978 PMID： 343816 DOI： 10.1016/0005-2787(78)90120-x

Source DB: PubMed Journal: Biochim Biophys Acta ISSN： 0006-3002

Keyword Cloud
Cited

× No keyword cloud information.

11 in total

1. Inhibitors of protein synthesis identified by a high throughput multiplexed translation screen.

Authors: Olivia Novac; Anne-Sophie Guenier; Jerry Pelletier
Journal: Nucleic Acids Res Date: 2004-02-09 Impact factor: 16.971

2. Antitumor Agents. 282. 2'-(R)-O-acetylglaucarubinone, a quassinoid from Odyendyea gabonensis as a potential anti-breast and anti-ovarian cancer agent.

Authors: Yoshihide Usami; Kyoko Nakagawa-Goto; Jing-Yu Lang; Yoon Kim; Chin-Yu Lai; Masuo Goto; Nobuko Sakurai; Masahiko Taniguchi; Toshiyuki Akiyama; Susan L Morris-Natschke; Kenneth F Bastow; Gordon Cragg; David J Newman; Mihoyo Fujitake; Koichi Takeya; Mien-Chie Hung; Eva Y-H P Lee; Kuo-Hsiung Lee
Journal: J Nat Prod Date: 2010-09-24 Impact factor: 4.050

3. Brusatol overcomes chemoresistance through inhibition of protein translation.

Authors: Bryan Harder; Wang Tian; James J La Clair; Aik-Choon Tan; Aikseng Ooi; Eli Chapman; Donna D Zhang
Journal: Mol Carcinog Date: 2017-02-08 Impact factor: 4.784

4. Omacetaxine: a protein translation inhibitor for treatment of chronic myelogenous leukemia.

Authors: Varsha Gandhi; William Plunkett; Jorge E Cortes
Journal: Clin Cancer Res Date: 2014-02-05 Impact factor: 12.531

5. Antimalarial activity of simalikalactone E, a new quassinoid from Quassia amara L. (Simaroubaceae).

Authors: N Cachet; F Hoakwie; S Bertani; G Bourdy; E Deharo; D Stien; E Houel; H Gornitzka; J Fillaux; S Chevalley; A Valentin; V Jullian
Journal: Antimicrob Agents Chemother Date: 2009-08-10 Impact factor: 5.191

6. Clinical pharmacology of bruceantin by radioimmunoassay.

Authors: K L Fong; D H Ho; R S Benjamin; N S Brown; A Bedikian; B S Yap; C L Wiseman; W Kramer; G P Bodey
Journal: Cancer Chemother Pharmacol Date: 1982 Impact factor: 3.333

7. U2504 determines the species specificity of the A-site cleft antibiotics: the structures of tiamulin, homoharringtonine, and bruceantin bound to the ribosome.

Authors: Güliz Gürel; Gregor Blaha; Peter B Moore; Thomas A Steitz
Journal: J Mol Biol Date: 2009-04-09 Impact factor: 5.469